Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HID1 domain-containing protein (HID1) is a highly conserved peripheral membrane protein associated with the medial and trans-Golgi apparatus. It is required for secretory granule maturation and is implicated in cellular processes such as insulin processing and vacuole fusion. While HID1 is proposed to participate in intracellular trafficking, its exact function and structural domains are poorly characterized, and it does not belong to any major drug target class such as receptor, enzyme, or transporter. HID1 mutations are associated with developmental and epileptic encephalopathy 105 with hypopituitarism. There is some evidence for down-regulation of HID1 in multiple cancers, but it is not a validated therapeutic target and there are currently no drugs known to interact with it[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HID1 domain-containing protein (HID1).